3 ms·
From the article: >It was the biggest biotech IPO ever in the U.S., raising $360 million. It has largely held up, too. Axovant’s shares, which opened at $15, c
by SpeakMouthWords 10y ago
From the article:
>It was the biggest biotech IPO ever in the U.S., raising $360 million. It has largely held up, too. Axovant’s shares, which opened at $15, currently trade around $13.25.
and further down:
> When Axovant went public, a columnist at FierceBiotech warned that it should “scare the hell” out of investors